It is known that benign and malignant breast cancer feature different T1 relaxation, the use of T1 relaxation in differential diagnosis has been reported. However accurate measurement of T1 relaxation requires knowledge of B1 distribution, which is inhomogeneous in breast. Synthetic MRI offers B1 corrected T1 relaxation time, its use breast cancer diagnosis has not yet been reported. Here, the use of the T1 mapping in synthetic MR in differential diagnosis of benign and malignant cancer is investigated. Our results demonstrated that T1 mapping offered by synthetic MR may be a potential quantitative biomarker for diagnosis of breast cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords